retatrutide triple agonist obesity trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more: https://go.lilly.com/msrz1v retatrutide phase 2 trial obesity

By choosing Klinic for your Zepbound treatment in Maryland, you secure access to: Expert providers specializing in weight management personalized to you Comprehensive insurance verification before treatment initiation Prior authorization handling and denial appeals FDA-approved branded medications only, ensuring regulated, high-quality treatment Ongoing care with regular check-ins and dosing adjustments 24/7 support from a dedicated care team At Klinic, getting a Zepbound prescription is made simple

2003 Jun;30(2):405-26, viii

The most frequent associated risk factor was blood transfusion (72.5%)

The maximum recommended maintenance dose is 15 mg once weekly

Initially, you might feel that your bowel movements are slowing down in frequency